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Fabrication of Large Size Ex Vivo-Produced Oral
Mucosal Equivalents for Clinical Application
Hiroko Kato, DDS, PhD,1,2 Cynthia L. Marcelo, PhD,1 James B. Washington, BS,1
Eve L. Bingham, BS,1 and Stephen E. Feinberg, DDS, MS, PhD1
The soft tissue reconstruction of significant avulsed and/or surgically created tissue defects requires the ability
to manufacture substantial soft tissue constructs for repair of the resulting wounds. In this study, we detail the
issues that need to be addressed in upsizing the manufacture of larger tissue-engineered devices (ex vivo-
produced oral mucosa equivalent [EVPOME]) in vitro from a methodology previously used for smaller con-
structs. The larger-sized EVPOME, consisting of autologous human oral keratinocytes and a dermal substitute,
AlloDerm, was fabricated for the purpose of reconstructing large clinical defects. Regulated as an autologous
somatic cell therapy product, the fabrication process abided by current Good Manufacturing Practices and
current Good Tissue Practices as required by the Center for Biologics Evaluation and Research (CBER) of the
United States Food and Drug Administration (FDA). Successful fabrication of large EVPOMEs utilized a
higher cell seeding density (5.3· 105 cells/cm2) with a relatively thinner AlloDerm, ranging from 356.6 to
508.0mm in thickness. During the air–liquid interface culture, the thickness of the scaffold affected the medium
diffusion rate, which, in turn, resulted in changes of epithelial stratification. Histologically, keratinocyte pro-
genitor (p63), proliferation (Ki-67), and late differentiation marker (filaggrin) expression showed differences
correlating with the expression of glucose transporter-1 (GLUT1) in the EVPOMEs from the thickest (550–
1020mm) to the thinnest (228.6–330.2mm) AlloDerm scaffold. Glucose consumption and 2-deoxyglucose
(2DG) uptake showed direct correlation with scaffold thickness. The scaffold size and thickness have an impact
on the cellular phenotype and epithelial maturation in the manufacturing process of the EVPOME due to the
glucose accessibility influenced by the diffusion rate. These outcomes provide basic strategies to manufacture a
large-sized, healthy EVPOME graft for reconstructing large mucosa defects.
Introduction
Reconstructive procedures of the oral cavity oftenresult in open wounds in the mouth, requiring the need
for mucosal tissue for intraoral reconstructive surgery. A
free mucosal graft used for reconstruction or closure of the
open wounds can prevent microbial infection, excessive
fluid loss, and foreign material contamination or relapse
secondary to wound contracture. Oral mucosa and skin
grafts, both requiring the harvesting of tissue from a second
surgical site, can result in increased patient morbidity.1 In
addition, oral mucosa is limited in supply, while split-
thickness skin grafts, although more easily available, con-
tain adnexal structures and express a different pattern of
keratinization.2 Thus, clinical needs for regeneration of oral
soft tissue remain to be solved.
Previously, we reported a clinical trial of the ex vivo-
produced oral mucosa equivalent (EVPOME) device that
demonstrated safety for intraoral grafting and that validated
its use to augment the development of keratinized tissue
around teeth.3,4 A circular piece of EVPOME 20mm in
diameter (3.14 cm2) was sufficient for small areas of peri-
odontal procedures; however, a larger EVPOME graft is
necessary for tumor, trauma, and other potential recon-
structive surgical procedures requiring significant amounts
of soft tissue. In fact, for resurfacing larger defects, we
need to manufacture multiple circular pieces of 3.14 cm2
EVPOMEs due to few product lines of cell culture.3,4 The
size of the 3 · 5 cm EVPOME has been manufactured under
the investigator-initiated phase I/II clinical trial for vesti-
buloplasty at the University of Michigan. The size of
3 · 5 cm was selected because it is sufficient to cover alve-
olar mucosa for the placement of several dental implants.
Scaffold design is well investigated in tissue engineering.
The optimal design to provide a suitablemicroenvironment for
cells varies with cell type, culture condition, and material.5
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AlloDerm (LifeCell, Branchburg, NJ) is an acellular human
dermal matrix having structures of polarity and porosity. Var-
ious thicknesses of AlloDerm are commercially available;
however, the effect of varying thicknesses on the fabrication of
tissue-engineered mucosa/skin still remains unclear.
Glucose consumption of EVPOMEs was successfully
used as a quality control test in the last clinical trial as it
reflects the viable cell number of the product.3,6 Although
glucose metabolism of keratinocytes is important for epi-
thelial proliferation and differentiation, there are few studies
investigating the effects of glucose on keratinocytes in a
three-dimensional culture condition,7,8 while several tissue-
engineered oral mucosa constructs have been developed for
a disease model, evaluation of drug delivery systems, and
clinical transplantation.9–11
The aim of this study is the fabrication of a 15 cm2
EVPOME for reconstruction of significant soft tissue defects.
Parametrics examined include the effects of the scaffold
thickness on cellular phenotype, the epithelial maturation of
the keratinocytes, and glucose metabolism.
Materials and Methods
Procurement of human oral mucosa
Keratinized oral mucosa was obtained from eight pa-
tients; three males and five females with a mean age of 42.5
years without any malignancies undergoing tooth extraction
and/or minor dentoalveolar surgery. The protocol for har-
vesting human oral mucosal tissue was approved by a
University of Michigan Internal Review Board.
Primary oral keratinocytes and serial cultures
As described previously, with modification,12 mucosal
tissue was digested overnight with 0.04% trypsin solution
(Life Technologies, Carlsbad, CA) with 19.25mg/mL of
gentamicin (Life Technologies) and 0.765mg/mL of fungi-
zone (Life Technologies) at room temperature and transferred
into 0.0125% defined trypsin inhibitor (DTI; Life Technolo-
gies) to neutralize the trypsin solution. Oral keratinocytes
were mechanically dissociated from the submucosal con-
nective tissue, collected, and centrifuged. Dissociated oral
keratinocytes were resuspended in a chemically defined cul-
ture system (EpiLife, supplemented with Epilife defined
growth supplement (EDGS) and 0.06mM calcium; Life
Technologies) and seeded into one T-25 flask (Corning,
Corning, NY). Ambient oxygen in an incubator at 37C in a
humidified 5.0% CO2 environment was used for following
the culture procedure. For the serial cultures, cells were de-
tached in 0.025% trypsin/EDTA (Life Technologies) and
neutralized by DTI. P2–P4 were used for the experiments.
Cultureware design and fabrication
of large size EVPOME
We designed a 30 · 50· 15mm corral and a 95mm di-
ameter · 5mm height waffle grid made of an acrylonitrile–
butadiene–styrene (ABS) plastic, which were made by
University of Michigan 3D Laboratory using fused deposi-
tion modeling with a Dimension Elite FDM 3D Printer
(Stratasys, Eden Prairie, MN). EVPOMEs were fabricated
as previously reported with modifications of cell number
and size.3 A corral was put on the inside of a 100-mm
culture dish (Corning) and glued on the dish with Indermil
(n-butylcynoacrylate) tissue adhesive (Henkel KgaA, Du¨s-
seldorf, Germany). Once the corrals were glued in place, a
3 · 5 cm piece of AlloDerm, presoaked with human type IV
collagen (5mg/cm2) (Sigma-Aldrich, St. Louis, MO), was
placed inside of the corral composite. P2–P4 oral mucosa
keratinocytes with the seeding densities of 6.6 · 105,
5.3 · 105, 4.0 · 105, and 2.0 · 105 cells/cm2 were seeded
onto the AlloDerm and cultured submerged for a day with
20mL of the medium. Then, the cell-seeded AlloDerm was
moved to another dish with an unglued corral, which per-
mitted medium perfusion to the AlloDerm, but did not allow
the AlloDerm to move or float in the medium. Following 3
days in a submerged culture under the same condition as the
primary cell culture fed with 60mL of the medium, which
was changed every day, the construct was raised to an air–
liquid interface for an additional 7 days using a complex
comprising a waffle grid and a 75-mm transwell membrane
insert (Corning) in a 150-mm culture dish (Corning) fed
with 60mL of the medium, which was changed every other
day (Fig. 1).
Besides the 3 · 5 cm EVPOME, two different sizes of the
EVPOME (0.75 and 1.75 cm2) routinely fabricated in our
laboratory were identically cultured for comparison. A 48-
well plate was used for the 0.75 cm2 EVPOME during
submerged culture, and a 12-well plate was used for the
1.75 cm2 EVPOME. For air–liquid culture, a 75-mm trans-
well was used for either condition. EpiLife supplemented
with EDGS and 1.2mM calcium was used during the entire
manufacture of the EVPOME devices.
Optimization of cell seeding density by histology
and MTT assay
Four seeding densities stated above were tested for the
fabrication of the 3· 5 cm EVPOME. Day 11 EVPOME was
FIG. 1. Culture devices and pro-
cedure of large ex vivo-produced
oral mucosa equivalent (EV-
POME). (A) Glued corral on the
100-mm culture dish using In-
dermil. (B) Air–liquid interface
culture using a 150-mm dish with
waffle and a transwell insert from
days 4 to 11. Color images avail-
able online at www.liebertpub
.com/tec
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analyzed by histology and MTT staining to visualize viable
cells. A modified MTT assay was performed as previously
described13 to extrapolate the uniformity of viable cells present
within the EVPOMEs based on the 3·5 cm EVPOME culture.
The EVPOME was immersed in 10mL of the medium with
1mL of MTT (Roche Molecular Biochemicals, Indianapolis,
IN) at 37C for 3 h. Uniformity of viable cell distribution was
observed macroscopically.
Optimization of thickness of AlloDerm
Three different thicknesses of theAlloDerm, 228.6–330.2mm
(thin), 356.6 to 508.0mm (middle), and 550–1020mm (thick)
(Life Cell Cat. No. 101010, 101020, 102049), were used to
fabricate three different sizes of EVPOMEs: 15, 1.75, and
0.75 cm2. EVPOMEs (15 cm2) cultured for 4, 6, 8, and 11 days
were analyzed by histology and immunohistochemistry.
Histological and immunohistochemical examinations
EVPOMEs were fixed in 10% neutral formalin. Paraf-
fin-embedded specimens were cut into 5-mm sections and
stained with hematoxylin and eosin (HE) for histological
examination. For immunohistochemistry, sections were
heated in Tris–EDTA buffer (10mM Tris [Sigma-Al-
drich], 1 mM EDTA [Sigma-Aldrich], pH 9.0) for 20min.
After incubating the sections with 5% normal goat serum
(Fisher Scientific, Pittsburgh, PA) for 1 h at room tem-
perature, they were incubated overnight at 4C in a humidified
chamber with primary antibodies: mouse monoclonal antibody
against filaggrin (ab17808; Abcam, Cambridge, United King-
dom) (1:500), involucrin (ab68; Abcam) (1:5000), p63 (ven-
tana, 790-4509) (no dilution), a rabbit monoclonal antibody
against Ki-67 (ab16667; Abcam) (1:200), K15 (ab52816; Ab-
cam) (1:200), and a rabbit polyclonal antibody against GLUT1
(ab14683; Abcam) (1:200). The sections were incubated with
the goat anti-mouse IgG (H+L) secondary antibody, DyLight
488 conjugate (Thermo Scientific, Waltham, MA), or goat anti-
rabbit IgG (H+L) secondary antibody, DyLight 594 conjugate
(Thermo Scientific), for 90min in the dark. Glass coverslips
were mounted onto slides in Vectashield mounting medium
with DAPI (H-1200; Vector Laboratories, Burlingame, CA) for
DNA staining.
Liquid diffusion pattern analysis during
air–liquid interface culture
Three different thicknesses of the AlloDerm, 228.6–
330.2 mm (thin), 356.6–508.0 mm (middle), and 550–1020mm
(thick), were placed onto the air–liquid interface and incu-
bated with Ponceau S (Thermo Scientific), which is used for
protein staining. Theywere frozen inOTC compound (Sakura
Finetek, Torrance, CA) and then cut into 8-mm sections by
Leica CM1850 Cyrostat. The diffusion pattern was histolog-
ically observed.
Glucose consumption measurement
Large EVPOME culture supernatant aliquots were taken
at all the feeding days and glucose levels were measured
using the GlucCell (Cesco Bioengineering, Taichung,
Taiwan) glucose monitoring system. Fresh medium was
measured as baseline glucose, and hourly consumption of
glucose was calculated by the formula as follows:
½ðGB GSÞ=ti
where GB is the baseline glucose amount (mg/dL), GS is the
supernatant glucose amount (mg/dL), and ti is the time in
hours.
2-Deoxyglucose uptake assay
To measure glucose diffusion into the AlloDerm, uptake
of 2-deoxyglucose (2DG; Sigma-Aldrich) was measured.
Small EVPOMEs were fabricated as described above, and
glucose consumption of spent medium from days 3 to 4 was
analyzed to check viability. EVPOMEs were transferred to
the air–liquid interface and incubated for 3, 12, and 24 h
with Epilife containing 6mM of 2DG as substitution for d-
glucose. EVPOMEs were washed thrice with 200mM
Phloretin (Sigma-Aldrich)/PBS and lysed in RIPA buffer
(50mM Tris–HCl pH7.5, 150mM NaCl, 1% NP40, 0.25%
Na-deoxycholate, 10mg/mL BSA, 2mM EGTA). Following
sonication, cell lysates were collected and diluted to 1:50,
and 2DG uptake was quantified by the 2-Deoxyglucose
Uptake Measurement kit (Cosmo Bio, Tokyo, Japan). To
eliminate variations among individual cell strains, data from
the same cell strain were divided by the 3-h EVPOME of the
thin AlloDerm uptake value and multiplied by 100.
Statistical analysis
Results are presented as mean – standard deviation of
mean (SD) of the values obtained. Comparisons among
three different thicknesses were analyzed by the Tukey–
Kramer test after determining whether the samples were
normally distributed or not. A p-value of less than 0.05 was
considered statistically significant. Statcel 3 (OMS, Tokor-
ozawa, Japan) was used for statistical analysis.
Results
Optimization of cell number for a large device
The seeded cell density of 2.0 · l05 cells/cm2, which we
usually use for fabrication of up to 3 cm2 EVPOMEs resulted
in a discontinuous epithelial monolayer in the large manu-
factured EVPOME (15 cm2) (Fig. 2A), while the small
EVPOME (0.75 cm2) grew well at this cell density (Fig. 2E).
The seeded cell density of 4.0 · l05, 5.3 · l05, and 6.0 · l05
cells/cm2 produced a continuous epithelial layer (Fig. 2B–D);
however, the seeded cell density of 4.0 · l05 cells/cm2 pro-
duced fewer epithelial cell layers in the large EVPOME (Fig.
2B). The epithelial layer of the small EVPOME sloughed off
during processing of the paraffin block in seeded cell densities
of 5.3 · l05 and 6.0 · l05 cells/cm2 (Fig. 2F–G). These data
indicated that seeding cell density is not proportional to the
surface area of the scaffold and can result in an incomplete
stratified cell layer, as seen in Figure 2F and G.
We examined the distribution of formazan crystal-posi-
tive cells using an MTT assay to assess the epithelial cov-
erage of large-sized EVPOME grafts macroscopically
(Supplementary Fig. S1; Supplementary Data are available
online at www.liebertpub.com/tec). Xu et al. (2009)13 re-
ported that all of the formazan crystal-positive cells were
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viable and localized to the basal layer and suprabasal layer in
EVPOMEs. In the macroscopic view of EVPOMEs, seeded cell
densities of greater than 5.3· l05 cells/cm2 showeduniformity of
viable cell distribution, while a seeded cell density of 2.0· l05
cells/cm2 showed areas of cell deficiency (Supplementary Fig.
S1A, B). Thus, to achieve an epithelial formation on the entire
surface of a 3·5 cmpiece ofAlloDerm, aminimumseeding cell
density of 5.3· l05 cells/cm2 was determined and used for large
EVPOME fabrication for subsequent analysis.
Histological analysis of EVPOMEs of three different
thicknesses and on day 11
In the large 3· 5 cm EVPOME, HE staining of thin and
middle thicknesses of AlloDerm showed well-stratified epi-
thelium (Fig. 3A, B), while less epithelial formation was
observed in the EVPOME of thick AlloDerm (Fig. 3C).
However, epithelial stratification differences among three Al-
loDerm thicknesses were not obvious in 0.75 and 1.75 cm2 size
EVPOMEs (Fig. 4D–I). Liquid diffusion pattern was visual-
ized by ponceau S. The thin and thick AlloDerm had the same
diffusion pattern from the bottom and edge (Fig. 4).
In immunohistochemical analysis, fewer Ki-67 (Fig. 5G–
I, red) and merged expression of p63 and DAPI (Fig. 5J–L,
green) with lower density of basal cells were observed in the
EVPOME of thick AlloDerm (Fig. 5I, L) than EVPOMEs
grown on middle and thin AlloDerm (Fig. 5G, H, J, K).
Keratinocyte basal cell marker, K15 (red), and early dif-
ferentiation marker, involucrin (green), were observed in all
samples (Fig. 5D–F); however, a keratinocyte late differ-
entiation marker, filaggrin, was very weak in the EVPOME
grown on thick AlloDerm (Fig. 5I, green). Results of
staining of all the three AlloDerm thicknesses with the size
of 15 cm2 showed significant activity of GLUT1, a glucose
transporter, in the thin and medium AlloDerm EVPOMEs
(Fig. 5J, K, red), while very light staining was seen in the
thick AlloDerm EVPOME (Fig. 5L). DAPI blue staining
showed the presence of abundant nuclei in all EVPOMEs
(Fig. 5A–L).
Morphology and protein expression during sequential
epithelial development
Monolayer epithelial morphology was observed by HE
staining of EVPOMEs grown on thin, medium, and thick
AlloDerm on day 4 (Fig. 6A, J, S), which is the time point at
which the EVPOME is airlifted for full tissue development
of the device. Epithelial stratification differences in different
AlloDerm thicknesses were seen over time. The epithelium
development of the EVPOME grown on thick AlloDerm
FIG. 2. Optimization of seeding density of large-sized EVPOME and comparison with small-sized EVPOME (scale
bar= 50mm). Hematoxylin and eosin (HE) staining of large EVPOME (15 cm2) with seeded cell density of 2.0· l05 (A),
4.0· l05 (B), 5.3· l05 (C), and 6.0· l05 cells/cm2 (D). Small EVPOME (0.75 cm2) with seeded cell density of 2.0· l05 (E),
4.0· l05 (F), and 5.3· l05 cells/cm2 (G). Color images available online at www.liebertpub.com/tec
FIG. 3. HE staining of EVPOMEs of three different thicknesses and sizes (A–C, scale bar = 100 mm; D–I, scale bar=
50 mm). EVPOME size; (A–C) 15, (D–F) 1.75, and (G–I) 0.75 cm2. AlloDerm thickness; (A, D, G) 228.6–330.2 (thin),
(B, E, H) 355.6–508.0 (middle), and (C, F, I) 550–1020mm (thick). Hematoxylin and eosin (HE) staining of large-sized
EVPOMEs of thin and middle thicknesses of AlloDerm showed well-stratified epithelium, while less epithelial formation was
observed in EVPOME of thick AlloDerm. However, epithelial stratification differences among three AlloDerm thicknesses
were not obvious in 0.75 and 1.75 cm2 size EVPOMEs. Color images available online at www.liebertpub.com/tec
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was the slowest (Fig. 6S–U). EVPOMEs of thin and middle
thicknesses of AlloDerm had better stratification of the ep-
ithelium than EVPOMEs of thick AlloDerm (Fig. 6A–C, J–
L, S–U).
In immunohistochemical analysis, using a number of
markers of differentiation and proliferation, the expression
patterns of EVPOMEs of thin and middle thicknesses of
AlloDerm were similar (Fig. 6D–I, M–R). In the thick Al-
loDerm EVPOME, less expression of Ki-67 was observed
after day 6 when compared with EVPOMEs grown with thin
and middle thicknesses of AlloDerm, and decreasing ex-
pression of filaggrin was seen during the entire culture pe-
riod (Fig. 6D–F, M–O, V–X). p63 and GLUT1 were equally
expressed on day 4 EVPOMEs in all samples (Fig. 6G, P,
Y). After day 6, the expression of both p63 and GLUT1 was
decreased in the EVPOME of thick AlloDerm (Fig. 6Z,
AA); however, it gradually increased in thin and middle
thicknesses of EVPOMEs (Fig. 6H, I, Q, R).
FIG. 4. Liquid diffusion pattern of AlloDerm (scale
bar= 200mm). (A, C) Thin AlloDerm, (B, D, E) thick
AlloDerm, (A, B) 8, (C, D) 48, (E) 96, and (F) 144h
of incubation. Both thin and thick AlloDerm showed
the same pattern of diffusion from the bottom and
edge. Color images available online at www
.liebertpub.com/tec
FIG. 5. Effects of AlloDerm thickness to the keratinocytes on day 11 large EVPOME characterized by immunohisto-
chemistry (scale bar = 50mm). AlloDerm thickness: (A, D, G, J) thin, (B, E, H, K) middle thickness, and (C, F, I, L) thick.
(A–C) HE staining; EVPOME of thick AlloDerm showed decreasing epithelial stratification. (D–F) Involucrin (green),
epithelial early differentiation marker, K15 (red), epithelial basal cell marker; involucrin-expressed suprabasal layer of all
samples. K15 expression was weak in EVPOME of thick AlloDerm. (G–I) Filaggrin (green), epithelial late differentiation
marker, Ki-67 (red), proliferation marker; decreasing expression of filaggrin and Ki-67 was observed in EVPOME of thick
AlloDerm. (J–L) p63 (green), epithelial progenitor marker, GLUT1 (red), glucose transporter; decreasing expression of p63
and GLUT1 was observed in EVPOME of thick AlloDerm. DAPI (blue) was used for DNA staining in (D–L). Color images
available online at www.liebertpub.com/tec
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Glucose consumption
During submerged culture (days 0–4), all three thicknesses
of EVPOMEs had similar glucose consumption. However,
during air–liquid interface (days 6–11) EVPOMEs using
thick AlloDerm showed lower glucose consumption than thin
and middle thicknesses. Statistical differences were noted on
thick AlloDerm versus thin and middle thicknesses of Allo-
Derm on day 10 ( p< 0.05) (Fig. 7).
2-Deoxyglucose uptake
The EVPOMEs constructed using thin AlloDerm took
up the greatest amount of 2DG at the 3-h time point,
which is when the EVPOME was transferred to the air–
liquid interface (Fig. 8). EVPOMEs growing on middle
thickness of AlloDerm showed highest uptake at 12 h.
These results would seem to indicate that 2DG diffused
through the AlloDerm to the cells growing on the top at
varying rates over time. In contrast, EVPOMEs con-
structed using thick AlloDerm showed lower levels of
2DG uptake. This would imply that a sufficient amount
of glucose for keratinocyte growth and proliferation was
not available for the cells grown on thick AlloDerm.
Uptake data of all EVPOMEs at the 24-h time point
showed decreasing of 2DG uptake because of cell death
since 2DG is not metabolized to produce ATP in the
cells. Statistical differences were noted on thin AlloDerm
versus middle thickness ( p< 0.05) and thick AlloDerm
( p< 0.01) at 3 h (Fig. 8).
Discussion
To engineer large autologous tissue is a challenge.14
An equipment design of a specific shape and size and a
scaffold suitable for cell proliferation and differentiation
are needed.14 In addition, the fabrication protocol should
be consistent with the guidelines for cell-based products
developed by the Center for Biologics Evaluation and
Research (CBER) of the United States Food and Drug
Administration (FDA). In this study, we were able to
utilize original cultureware from commercialized culture
dishes, ABS plastics, and cyanoacrylate that were cell
safe materials.
We investigated the optimal number of cells necessary to
fabricate a large EVPOME. Our past studies indicated that a
FIG. 6. Effects of AlloDerm thickness on keratino-
cytes during air–liquid culture of large EVPOME
characterized by immunohistochemistry (scale bar = 50
mm). AlloDerm thickness: (A–I) thin, ( J–R) middle
thickness, and (S–AA) thick. Day of culture: (A, D, G,
J, M, P, S, V, Y) day 4, (B, E, H, K, N, Q, T, W,
Z) day 6, and (C, F, I, L, O, R, U, X, AA) day 8.
HE staining (A, B, C, J, K, L, S, T, U). EVPOME of
thick AlloDerm showed decreasing epithelial stratifi-
cation (S, T, U). Immunohistochemistry (D, E, F, M,
N, O, V, W, X). Filaggrin (green), epithelial late
differentiation marker, Ki-67 (red), proliferation
marker; decreasing expression of Ki-67 was observed
in EVPOME of thick AlloDerm after day 6 (W, X)
and decreasing expression of filaggrin was observed
during the entire culture period (V, W, X). Im-
munohistochemistry (G, H, I, P, Q, R, Y, Z, AA).
p63 (green), epithelial progenitor marker, GLUT1 (red)
glucose transporter; both GLUT1 and p63 expression
was observed in all samples on day 4; however,
gradual decreasing of their expression was observed in
EVPOME of thick AlloDerm after day 6 (Z, AA).
DAPI was used to stain the cell nuclei in the epithe-
lium. Color images available online at www.lie-
bertpub.com/tec
FIG. 7. Glucose consumption of large EVPOME
(N = 5). The EVPOMEs are submerged in the medium
until they are airlifted on day 4. Glucose consump-
tion on day 10 is statistically different between EV-
POME of thick AlloDerm versus thin and middle
thicknesses of AlloDerm. Asterisks represent statistically
significant differences determined by repeated one-way
analysis of variance with the Tukey–Kramer post hoc
test) (*p < 0.05). Color images available online at www
.liebertpub.com/tec
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seeding cell density of 2.0 · 105 cells/cm2 was needed for up
to 3.14 cm2 EVPOMEs. This cell density was not optimal to
make larger 3· 5 cm EVPOMEs as shown in Figure 2. This
was also confirmed by an MTT assay, which allows us to
assess the epithelium coverage of the large-sized EVPOME
grafts macroscopically and rapidly with low cost. This
study revealed that a seeding cell density of 5.3 · 105 cells/
cm2 was necessary to fabricate EVPOMEs with sufficient
stratification of the uppermost epithelium. It was noted that
at a seeding cell density of 6.6 · 105 cells/cm2, the epi-
thelial structure showed no difference when compared with
5.3· 105 cells/cm2. This would indicate that a larger seeding
cell number might not make a difference in cellular stratifi-
cation after a resulting cell monolayer has been established.
However, an excessive number of seeded cells might ad-
versely affect the epithelial layer and be sloughed off as seen
using a smaller size AlloDerm with a seeded cell density of
5.3 · l05 cells/cm2. These results are consistent with our
previous study.15
In 3 · 5 cm EVPOMEs, scaffold thickness differences
affected the stratification of the epithelium caused by vari-
ations in glucose diffusion through the AlloDerm during the
air–liquid interface period of EVPOME construction in
culture. Decreasing expression of filaggrin in EVPOMEs
grown using thick AlloDerm would indicate a compromised
tissue protection by the EVPOME to outside damage after
transplantation onto the wound site since filaggrin plays a
role in barrier function.
Glucose uptake of the EVPOME of middle thickness Al-
loDerm was significantly slower than the thin AlloDerm;
however, it did not impact epithelial proliferation and dif-
ferentiation between EVPOMEs of thin and middle thick-
nesses of AlloDerm. Stratification differences among the
three different AlloDerm thicknesses in small and middle-
sized EVPOMEs were not evident. The diffusion pattern re-
vealed by Ponceau S indicated that liquid diffuses from the
bottom and edges when the AlloDerm is at an air–liquid
interface. Thus, the smaller the size of the scaffold, the lower
the effect of the diffusion would be on the viability, growth,
and differentiation of the seeded cells. In contrast, the larger
piece of AlloDerm showed a lower diffusion rate that affected
cell viability within the central portion of the scaffold.
Therefore, the slow diffusion observed in the thick and large-
sized AlloDerm would lead to the limited availability and a
concentration gradient of other biological cues, including
oxygen and growth factors regulating keratinocyte fate.16
We investigated glucose as a representative nutrition.
However, it is reported that glucose permeability of de-
epithelialized dermis and rat keratinocytes is faster than li-
pophilic corticosterone,17 suggesting that the diffusion rate
of other medium nutrients might also affect the stratification
of keratinocytes in our culture system. Previous studies in-
dicated that GLUT1, which is located along the basal epi-
thelial layer, might play an important role in mediating
nutrient and fluid supply to the upper layers of the epithe-
lium from the underlying stroma.8,18,19 The reduced GLUT1
expression represents a shift from glucose-dominated to fat-
dominated metabolism during the differentiation process of
basal cells into superficial keratinocytes.20,21 The reduction
of GLUT1 expression in the EVPOME using thick Allo-
Derm after being raised at an air–liquid interface culture
supports the finding that it consumes and metabolizes less
amount of glucose because of its limited availability through
diffusion through a thicker AlloDerm. In addition, the sig-
nificant drop of the glucose consumption of the large EV-
POME using thick AlloDerm at day 10 was correlated with
the decrease in the number of Ki-67-positive cells, which
may result from a decline in energy demand by mitotic
activity.22 Keratinocytes seeded in this slowed diffusion
environment might be under starvation-like conditions
during the air–liquid interface culture.
Under energy starvation conditions, cells restore the energy
balance and protect cells from energy deprivation-dependent
apoptosis.23 HaCaT cells cultured in high calcium with low-
glucose condition showed the progressive cell quiescence and
gradual commitment into early differentiation without cell
death when compared with normal glucose.24 DNp63 re-
sponses of glucose starvation and TAp63 are critical regula-
tors of lipid and glucose metabolism, regulating and
integrating the metabolic response to caloric restriction and
starvation.25,26 Pan-p63 is crucial to the development of
stratifying epithelia in humans and plays a multifaceted role
in the mature epidermis,26 and Truong et al. (2006)27 reported
that human primary keratinocytes, in a 3D culture model
using cells with knocked down pan-p63, showed decreased
expression of proliferation and differentiation proteins. Our
findings of glucose uptake, p63 expression, and differentia-
tion seen in EVPOMEs of thick AlloDerm are consistent with
those studies. Because of low-glucose utility, keratinocytes
on the thick AlloDerm are assumed to exist in a low me-
tabolism condition that leads to decreasing of pan-p63 ex-
pression, resulting in a diminution of cellular proliferation,
stratification, and late differentiation while occurrence of
FIG. 8. 2-Deoxyglucose (2DG) uptake assay during air–
liquid interface culture (N= 5). All 2DG uptake data from the
same cell strain were divided by the 3-h value of EVPOME
growing on thin AlloDerm, and % change of 3-h uptake of
EVPOME using thin AlloDerm is shown. Thus, 3-h thin
AlloDerm value is shown as 100%. The lower number (%)
indicates that the amount of 2DG uptake is smaller compared
with that of 3-h thin AlloDerm. Asterisks represent statisti-
cally significant differences determined by repeated one-way
analysis of variance with the Tukey–Kramer post hoc test)
(*p< 0.05 and **p< 0.01). Color images available online at
www.liebertpub.com/tec
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early differentiation. There might be a critical scaffold thick-
ness that deteriorates the quality of epithelium within the
EVPOME, highly likely to be the thickness that exceeds the
middle one. This study would seem to indicate that the cellular
phenotype regulated by glucose metabolism during epithelial
development on tissue-engineered culture is influenced by
scaffold thickness, size, and medium diffusion.
In situ studies indicate that a scaffold thickness less than
1mm of biomaterials encourages rapid regeneration, and
grafts thicker than 1mm have a higher incident of graft
failure after transplantation since new blood vessels cannot
grow quickly enough into the scaffold to nourish the over-
laying epidermal layer.28,29 Efficient diffusion of nutrition
through the dermal scaffold is a key factor to create a well-
stratified EVPOME. This would also impact on wound
healing after transplantation since growth factor(s) secreted
by keratinocytes on the EVPOME could reach the host
quicker to induce vascularization. Therefore, material
thickness has direct implications on its functionality both
in vitro and in vivo.
Conclusion
This study determined that a higher number of cells
(5.3 · 105 cells/cm2) is necessary to seed onto the large size
scaffold for the fabrication of 3 · 5 cm (15 cm2) EVPOME
grafts that exhibit a well-stratified epithelium optimal for
use in reconstruction of severe trauma, deformity, and
cancer resection. Histological and immunohistochemical
examinations in this study also demonstrated that the well-
differentiated and proliferative epithelial layer was devel-
oped within the EVPOME graft using AlloDerm thinner
than 508.0 mm in thickness when fabricating a large-sized
15 cm2 EVPOME. This was due to sufficient glucose
availability for keratinocytes in the basal layer as confirmed
by an increase in their glucose consumption and uptake.
Thus, the scaffold size and thickness have an impact on the
cellular phenotype and epithelial maturation in the
manufacturing process of the EVPOME due to the glucose
accessibility influenced by the diffusion rate. These out-
comes provide basic strategies to manufacture a large-sized
and healthy EVPOME graft for reconstructing large mucosa
defects.
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